Literature DB >> 19929931

Asian perspectives in the management of inflammatory bowel disease: findings from a recent survey.

Joseph J Y Sung1, Michael A Kamm, Philippe Marteau.   

Abstract

BACKGROUND AND AIM: The prevalence and incidence of inflammatory bowel disease (IBD) differs worldwide. While the prevalence of IBD has stabilized in Europe, the USA and Japan, an increasing trend has been observed in Asia. However, there are no data on the current clinical practice for the management of IBD in the region. The present study aims to investigate the number of existing and new cases of IBD and to understand the current practice of diagnosis and treatment of IBD in different Asian countries.
METHODS: A self-administered questionnaire, designed according to European and US guidelines, was distributed to IBD specialists throughout Asia. The questionnaire estimated the annual incidence of existing and new IBD cases in physicians' clinical practices and evaluated their procedures of diagnosis and preference for therapeutic treatment and maintenance treatment.
RESULTS: Eighty-seven questionnaires were received out of the 107 distributed. In the clinical practices of these 87 respondents, there were 502 existing and 73 new cases per year for ulcerative colitis (UC) and 202 existing and 32 new cases per year for Crohn's disease (CD). Colonoscopy and histology were the most commonly used methods for the diagnosis of UC and CD, but clinical practice regarding the diagnosis of IBD varied. The treatment of choice for mild-to-moderate UC and CD was 5-aminosalicylic acid (5-ASA), which is also the preferred choice for the maintenance treatment of UC and CD.
CONCLUSION: Clinical practice with regards to IBD diagnosis and management varies within Asia.5-ASA is the preferred treatment and maintenance therapy for mild-to-moderate IBD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19929931     DOI: 10.1111/j.1440-1746.2009.06024.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

1.  Indian Society of Gastroenterology consensus statements on Crohn's disease in India.

Authors:  Balakrishnan S Ramakrishna; Govind K Makharia; Vineet Ahuja; Uday C Ghoshal; Venkataraman Jayanthi; Benjamin Perakath; Philip Abraham; Deepak K Bhasin; Shobna J Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra Desai; Bhaba Dev Goswami; Sanjeev K Issar; Ajay K Jain; Rakesh Kochhar; Goundappa Loganathan; Sri Prakash Misra; C Ganesh Pai; Sujoy Pal; Mathew Philip; Anna Pulimood; Amarender S Puri; Gautam Ray; Shivaram P Singh; Ajit Sood; Venkatraman Subramanian
Journal:  Indian J Gastroenterol       Date:  2015-03-14

Review 2.  Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Sawan Bopanna; Ashwin N Ananthakrishnan; Saurabh Kedia; Vijay Yajnik; Vineet Ahuja
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-21

3.  Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.

Authors:  Soo Jung Park; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 4.  The Same Intestinal Inflammatory Disease despite Different Genetic Risk Factors in the East and West?

Authors:  Rashid N S Lui; Siew C Ng
Journal:  Inflamm Intest Dis       Date:  2016-07-15

5.  Indian Society of Gastroenterology consensus on ulcerative colitis.

Authors:  Balakrishnan S Ramakrishna; Govind K Makharia; Philip Abraham; Uday C Ghoshal; Venkataraman Jayanthi; Brij Kishore Agarwal; Vineet Ahuja; Deepak K Bhasin; Shobna J Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra C Desai; Gopal Krishna Dhali; Bhaba Dev Goswami; Sanjeev K Issar; Ajay K Jain; Rakesh Kochhar; Ajay Kumar; Goundappa Loganathan; Sri Prakash Misra; C Ganesh Pai; Sujoy Pal; Anna Pulimood; Amarender S Puri; Ganesh N Ramesh; Gautam Ray; Shivaram P Singh; Ajit Sood; Manu Tandan
Journal:  Indian J Gastroenterol       Date:  2012-10-25

6.  Safety and Efficacy of Adalimumab for Patients With Moderate to Severe Crohn's Disease: The Taiwan Society of Inflammatory Bowel Disease (TSIBD) Study.

Authors:  Chen-Wang Chang; Shu-Chen Wei; Jen-Wei Chou; Tzu-Chi Hsu; Chiao-Hsiung Chuang; Ching-Pin Lin; Wen-Hung Hsu; Hsu-Heng Yen; Jen-Kou Lin; Yi-Jen Fang; Horng-Yuan Wang; Hung-Hsin Lin; Deng Cheng Wu; Yen Hsuan Ni; Cheng-Yi Wang; Jau-Min Wong
Journal:  Intest Res       Date:  2014-10-27

7.  Healthcare professionals' views of the experiences of individuals living with Crohn's Disease in Spain. A qualitative study.

Authors:  Sofía García-Sanjuán; Manuel Lillo-Crespo; Miguel Richart-Martínez; Ángela Sanjuán-Quiles
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

8.  Initial medical and surgical management of inflammatory bowel disease in the biologic era: A comparison between the United States and China.

Authors:  Sanskriti Varma; Jun Hu; Ambar Mehta; Yiran Song; Angela Park; Min Zhi; Susan Hutfless
Journal:  JGH Open       Date:  2019-02-04

9.  Current diagnosis and management of Crohn's disease in China: results from a multicenter prospective disease registry.

Authors:  Yue Li; Baili Chen; Xiang Gao; Naizhong Hu; Meifang Huang; Zhihua Ran; Zhanju Liu; Jie Zhong; Duowu Zou; Xiaoping Wu; Jianlin Ren; Jianqiu Sheng; Ping Zheng; Huahong Wang; Minhu Chen; Junrong Chen; Peng Xi; Jiajia Lu; Malcolm Handel; Yanfang Liu; Hua Fan; Jiaming Qian
Journal:  BMC Gastroenterol       Date:  2019-08-16       Impact factor: 3.067

10.  The incidence rate of inflammatory bowel disease in an urban area of iran: a developing country.

Authors:  Mohammad Javad Zahedi; Sodaif Darvish Moghadam; Mehdi Hayat Bakhsh Abbasi; Masood Dehghani; Sara Shafiei Pour; Hamideh Zydabady Nejad; Kiekam Broumand
Journal:  Middle East J Dig Dis       Date:  2014-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.